相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Torsten Zuberbier et al.
ALLERGY (2022)
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings
Wan-Chun Chang et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria
Juan Li et al.
PHARMACOGENOMICS JOURNAL (2020)
Opportunities for pharmacists to integrate pharmacogenomics into clinical practice
Yan-Ting Wang et al.
PHARMACOGENOMICS JOURNAL (2020)
Histamine H1 receptor gene polymorphism acts as a biological indicator of the prediction of therapeutic efficacy in patients with allergic rhinitis in the Chinese Han population
Jin-Tao Chu
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder
M. S. Zastrozhin et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Terfenadine metabolism of human cytochrome P450 2J2 containing genetic variations (G312R, P351L and P115L)
Dabin Jeong et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Histamine H4 receptor gene polymorphisms: a potential predictor of oral H1 antihistamine efficacy for allergic rhinitis
Jian Gu et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2017)
Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine
Jie Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
The clinical pharmacology of non-sedating antihistamines
Kazuhiko Yanai et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children
Sandra Andorf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine
Marleen Julia Meyer et al.
PLOS ONE (2017)
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk The MESA Study
Peter J. Leary et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
CYP3A5*3 and MDR1 C3435T are influencing factors of inter-subject variability in rupatadine pharmacokinetics in healthy Chinese volunteers
Yuqing Xiong et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients
Maho Okubo et al.
BIOCHEMICAL PHARMACOLOGY (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1
Tina Seitz et al.
GENOME MEDICINE (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Update on rupatadine in the management of allergic disorders
J. Mullol et al.
ALLERGY (2015)
Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients
Aiyuan Guo et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2015)
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Pertti Panula et al.
PHARMACOLOGICAL REVIEWS (2015)
Influence of component 5a receptor 1 (C5AR1)-1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria
Siyu Yan et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
The SLCO (former SLC21) superfamily of transporters
Bruno Hagenbuch et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The role of P-glycoprotein in CNS antihistamine effects
Silke Conen et al.
PSYCHOPHARMACOLOGY (2013)
Histamine H1 receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers
Hirotoshi Sato et al.
PSYCHOPHARMACOLOGY (2013)
Molecular and cellular analysis of human histamine receptor subtypes
Roland Seifert et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Joerg Koenig et al.
PHARMACOLOGICAL REVIEWS (2013)
Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
Hua Rong Lu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
CRACM/Orai ion channel expression and function in human lung mast cells
Ian Ashmole et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Meclizine Metabolism and Pharmacokinetics: Formulation on Its Absorption
Zhijun Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Use of genome-wide association studies for drug repositioning
Philippe Sanseau et al.
NATURE BIOTECHNOLOGY (2012)
GeneSigDB: a manually curated database and resource for analysis of gene expression signatures
Aedin C. Culhane et al.
NUCLEIC ACIDS RESEARCH (2012)
Histamine H2-receptor antagonists for urticaria
Zbys Fedorowicz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Comparison of the Inhibitory Profiles of Itraconazole and Cimetidine in Cytochrome P450 3A4 Genetic Variants
Takeshi Akiyoshi et al.
DRUG METABOLISM AND DISPOSITION (2011)
Systematic analysis of histamine and N-methylhistamine concentrations in organs from two common laboratory mouse strains: C57Bl/6 and Balb/c
Anna Sophie Zimmermann et al.
INFLAMMATION RESEARCH (2011)
Histamine and H1-antihistamines: Celebrating a century of progress
F. Estelle R. Simons et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Membrane Position of Ibuprofen Agrees with Suggested Access Path Entrance to Cytochrome P450 2C9 Active Site
Karel Berka et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2011)
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype
Johannes G. Ramaekers et al.
PSYCHOPHARMACOLOGY (2011)
En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family
Rob Leurs et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Risk of first-generation H1-antihistamines: a GA2LEN position paper
M. K. Church et al.
ALLERGY (2010)
A histamine H2 receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade
Hiroyuki Takahama et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis
B. Yu et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Identification of Novel Substrates for Human Cytochrome P450 2J2
Caroline A. Lee et al.
DRUG METABOLISM AND DISPOSITION (2010)
CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
Keiko Maekawa et al.
DRUG METABOLISM AND DISPOSITION (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Curtis D. Klaassen et al.
PHARMACOLOGICAL REVIEWS (2010)
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers
Yumiko Akamine et al.
XENOBIOTICA (2010)
Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life
C. -M. Chen et al.
ALLERGY (2009)
Histamine H-3 and H-4 receptors as novel drug targets
Ekaterini Tiligada et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Desloratadine Inhibits Human Skin Mast Cell Activation and Histamine Release
Karsten Weller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Association of CRTH2 gene polymorphisms with the required dose of antihistamines in patients with chronic urticaria
Nami Shrestha Palikhe et al.
PHARMACOGENOMICS (2009)
Expression of multidrug resistance-related proteins p-glycoproteinglutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma
Hongcan Shi et al.
CANCER INVESTIGATION (2008)
The role of histamine H-1 and H-4 receptors in allergic inflammation: The search for new antihistamines
Robin L. Thurmond et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans
Soichiro Matsushima et al.
DRUG METABOLISM AND DISPOSITION (2008)
The clinical role of genetic polymorphisms in drug-metabolizing enzymes
D. Tomalik-Scharte et al.
PHARMACOGENOMICS JOURNAL (2008)
Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice
Xianbin Tian et al.
DRUG METABOLISM AND DISPOSITION (2008)
Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels
Monika Vig et al.
NATURE IMMUNOLOGY (2008)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2
Pierre Lafite et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17
Hongwu Shen et al.
DRUG METABOLISM AND DISPOSITION (2007)
Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues
Tracy C. DeLozier et al.
DRUG METABOLISM AND DISPOSITION (2007)
Calcium signalling in lymphocyte activation and disease
Stefan Feske
NATURE REVIEWS IMMUNOLOGY (2007)
Adding pharmacogenetics information to drug labels: lessons learned
Susanne B. Haga et al.
PHARMACOGENETICS AND GENOMICS (2006)
The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H1-receptor antihistamine ebastine:: a pilot study
Guillermo Gervasini et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
9α,11β-PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2
H Sandig et al.
FEBS LETTERS (2006)
Pharmacogenetics, drug-metabolizing enzymes, and clinical practice
Sharon J. Gardiner et al.
PHARMACOLOGICAL REVIEWS (2006)
Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
DL Bourdet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans
M Shimizu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Adult asthma severity in individuals with a history of childhood asthma
SL Limb et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Importance of P-glycoprotein at blood-tissue barriers
MF Fromm
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition
SY Yi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability
JL Huang et al.
HUMAN MOLECULAR GENETICS (2004)
Histamine in the immune regulation of allergic inflammation
CA Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells
CL Hofstra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
Y Shu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Who is using chronic acid suppression therapy and why?
BC Jacobson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole
S Matsumoto et al.
DRUG METABOLISM AND DISPOSITION (2002)
Clinical importance of the cytochromes P450
DW Nebert et al.
LANCET (2002)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
Trends in histamine research: new functions during immune responses and hematopoiesis
E Schneider et al.
TRENDS IN IMMUNOLOGY (2002)
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine
S Drescher et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
H1-antihistamines:: inverse agonism, anti-inflammatory actions and cardiac effects
R Leurs et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Identification of a histamine H4 receptor on human eosinophils -: Role in eosinophil chemotaxis
M O'Reilly et al.
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH (2002)
Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal Microsomes
T Hashizume et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Histamine H1-receptor activation of nuclear factor-κB:: Roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling
RA Bakker et al.
MOLECULAR PHARMACOLOGY (2001)
Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells
A Papi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Organic anion-transporting potypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
GA Kullak-Ublick et al.
GASTROENTEROLOGY (2001)
Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines
M Chishty et al.
JOURNAL OF DRUG TARGETING (2001)
Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes
T Oda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cardiotoxic potential and CNS effects of first-generation antihistamines
M Taglialatela et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists
RA Bakker et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine
N Okamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Factors involved in the absence of sedative effects by the second-generation antihistamines
H Timmerman
ALLERGY (2000)
分享论文
